These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2089 related items for PubMed ID: 28856924

  • 1. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN, Hatz C, Kantele A.
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [Abstract] [Full Text] [Related]

  • 2. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas.
    Whitaker JA, Franco-Paredes C, del Rio C, Edupuganti S.
    J Travel Med; 2009 Oct; 16(1):46-52. PubMed ID: 19192128
    [No Abstract] [Full Text] [Related]

  • 3. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH, Kantele JM, Kantele A.
    Vaccine; 2012 Sep 14; 30(42):6047-53. PubMed ID: 22858557
    [Abstract] [Full Text] [Related]

  • 4. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH, Kantele JM, Savolainen LE, Rombo L, Kantele A.
    Vaccine; 2015 Jan 09; 33(3):451-8. PubMed ID: 25433216
    [Abstract] [Full Text] [Related]

  • 5. Enteric fever in Israeli travelers: a nationwide study.
    Meltzer E, Sadik C, Schwartz E.
    J Travel Med; 2005 Jan 09; 12(5):275-81. PubMed ID: 16256052
    [Abstract] [Full Text] [Related]

  • 6. [Typhoid and paratyphoid fever].
    Trawinski H, Wendt S, Lippmann N, Heinitz S, von Braun A, Lübbert C.
    Z Gastroenterol; 2020 Feb 09; 58(2):160-170. PubMed ID: 32050286
    [Abstract] [Full Text] [Related]

  • 7. Overview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®).
    Amicizia D, Arata L, Zangrillo F, Panatto D, Gasparini R.
    J Prev Med Hyg; 2017 Mar 09; 58(1):E1-E8. PubMed ID: 28515625
    [Abstract] [Full Text] [Related]

  • 8. Population impact of Vi capsular polysaccharide vaccine.
    Khan MI, Ochiai RL, Clemens JD.
    Expert Rev Vaccines; 2010 May 09; 9(5):485-96. PubMed ID: 20450323
    [Abstract] [Full Text] [Related]

  • 9. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal.
    Schwartz E, Shlim DR, Eaton M, Jenks N, Houston R.
    Arch Intern Med; 1990 Feb 09; 150(2):349-51. PubMed ID: 2105702
    [Abstract] [Full Text] [Related]

  • 10. Enteric (typhoid) fever in travelers.
    Basnyat B, Maskey AP, Zimmerman MD, Murdoch DR.
    Clin Infect Dis; 2005 Nov 15; 41(10):1467-72. PubMed ID: 16231259
    [Abstract] [Full Text] [Related]

  • 11. Should close contacts of returning travellers with typhoid fever be protected by vaccination?
    Kantele A.
    Vaccine; 2015 Mar 17; 33(12):1419-21. PubMed ID: 25678244
    [Abstract] [Full Text] [Related]

  • 12. Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.
    Xiong K, Zhu C, Chen Z, Zheng C, Tan Y, Rao X, Cong Y.
    Front Cell Infect Microbiol; 2017 Mar 17; 7():135. PubMed ID: 28484685
    [Abstract] [Full Text] [Related]

  • 13. Enteric fever and its impact on returning travellers.
    Dave J, Sefton A.
    Int Health; 2015 May 17; 7(3):163-8. PubMed ID: 25808163
    [Abstract] [Full Text] [Related]

  • 14. Prospects of Future Typhoid and Paratyphoid Vaccines in Endemic Countries.
    Shakya M, Neuzil KM, Pollard AJ.
    J Infect Dis; 2021 Dec 20; 224(12 Suppl 2):S770-S774. PubMed ID: 34374785
    [Abstract] [Full Text] [Related]

  • 15. Typhoid vaccination for international travelers from Greece visiting developing countries.
    Smeti P, Pavli A, Katerelos P, Maltezou HC.
    J Travel Med; 2014 Dec 20; 21(2):99-103. PubMed ID: 24251544
    [Abstract] [Full Text] [Related]

  • 16. Typhoid and paratyphoid fever: a clinical seminar.
    Manesh A, Meltzer E, Jin C, Britto C, Deodhar D, Radha S, Schwartz E, Rupali P.
    J Travel Med; 2021 Apr 14; 28(3):. PubMed ID: 33550411
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of typhoid vaccination in US travelers.
    Mahon BE, Newton AE, Mintz ED.
    Vaccine; 2014 Jun 17; 32(29):3577-9. PubMed ID: 24837780
    [Abstract] [Full Text] [Related]

  • 18. Progress in the overall understanding of typhoid fever: implications for vaccine development.
    O'Reilly PJ, Pant D, Shakya M, Basnyat B, Pollard AJ.
    Expert Rev Vaccines; 2020 Apr 17; 19(4):367-382. PubMed ID: 32238006
    [Abstract] [Full Text] [Related]

  • 19. Vaccination against typhoid fever in travellers: a cost-effectiveness approach.
    Papadimitropoulos V, Vergidis PI, Bliziotis I, Falagas ME.
    Clin Microbiol Infect; 2004 Aug 17; 10(8):681-3. PubMed ID: 15301670
    [Abstract] [Full Text] [Related]

  • 20. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.
    Wahid R, Fresnay S, Levine MM, Sztein MB.
    Mucosal Immunol; 2015 Nov 17; 8(6):1349-59. PubMed ID: 25872480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 105.